eflornithine plus sulindac

· Cancer Prevention Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for eflornithine plus sulindac, covering 2021-06-08 to 2021-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP) [Phase 3]